Cargando…

Acute Macrovascular Dysfunction in Patients With Type 2 Diabetes Induced by Ingestion of Advanced Glycated β-Lactoglobulins

OBJECTIVE: Recent evidence indicates that heat-enhanced food advanced glycation end products (AGEs) adversely affect vascular function. The aim of this study was to examine the acute effects of an oral load of heat-treated, AGE-modified β-lactoglobulins (AGE-BLG) compared with heat-treated, nonglyca...

Descripción completa

Detalles Bibliográficos
Autores principales: Stirban, Alin, Kotsi, Paraskevi, Franke, Knut, Strijowski, Ulf, Cai, Weijing, Götting, Christian, Tschoepe, Diethelm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631855/
https://www.ncbi.nlm.nih.gov/pubmed/23238657
http://dx.doi.org/10.2337/dc12-1489
_version_ 1782266817542094848
author Stirban, Alin
Kotsi, Paraskevi
Franke, Knut
Strijowski, Ulf
Cai, Weijing
Götting, Christian
Tschoepe, Diethelm
author_facet Stirban, Alin
Kotsi, Paraskevi
Franke, Knut
Strijowski, Ulf
Cai, Weijing
Götting, Christian
Tschoepe, Diethelm
author_sort Stirban, Alin
collection PubMed
description OBJECTIVE: Recent evidence indicates that heat-enhanced food advanced glycation end products (AGEs) adversely affect vascular function. The aim of this study was to examine the acute effects of an oral load of heat-treated, AGE-modified β-lactoglobulins (AGE-BLG) compared with heat-treated, nonglycated BLG (C-BLG) on vascular function in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: In a double-blind, controlled, randomized, crossover study, 19 patients with T2DM received, on two different occasions, beverages containing either AGE-BLG or C-BLG. We measured macrovascular [brachial ultrasound of flow-mediated dilatation (FMD)] and microvascular (laser-Doppler measurements of reactive hyperemia in the hand) functions at baseline (T(0)), 90 (T(90)), and 180 (T(180)) min. RESULTS: Following the AGE-BLG, FMD decreased at T(90) by 80% from baseline and remained decreased by 42% at T(180) (P < 0.05 vs. baseline, P < 0.05 vs. C-BLG at T90). By comparison, following C-BLG, FMD decreased by 27% at T(90) and 51% at T(180) (P < 0.05 vs. baseline at T180). A significant decrease in nitrite (T(180)) and nitrate (T(90) and T(180)), as well as a significant increase in N(ε)-carboxymethyllisine, accompanied intake of AGE-BLG. There was no change in microvascular function caused by either beverage. CONCLUSIONS: In patients with T2DM, acute oral administration of a single AGE-modified protein class significantly though transiently impaired macrovascular function in concert with decreased nitric oxide bioavailability. These AGE-related changes were independent of heat treatment.
format Online
Article
Text
id pubmed-3631855
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-36318552014-05-01 Acute Macrovascular Dysfunction in Patients With Type 2 Diabetes Induced by Ingestion of Advanced Glycated β-Lactoglobulins Stirban, Alin Kotsi, Paraskevi Franke, Knut Strijowski, Ulf Cai, Weijing Götting, Christian Tschoepe, Diethelm Diabetes Care Original Research OBJECTIVE: Recent evidence indicates that heat-enhanced food advanced glycation end products (AGEs) adversely affect vascular function. The aim of this study was to examine the acute effects of an oral load of heat-treated, AGE-modified β-lactoglobulins (AGE-BLG) compared with heat-treated, nonglycated BLG (C-BLG) on vascular function in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: In a double-blind, controlled, randomized, crossover study, 19 patients with T2DM received, on two different occasions, beverages containing either AGE-BLG or C-BLG. We measured macrovascular [brachial ultrasound of flow-mediated dilatation (FMD)] and microvascular (laser-Doppler measurements of reactive hyperemia in the hand) functions at baseline (T(0)), 90 (T(90)), and 180 (T(180)) min. RESULTS: Following the AGE-BLG, FMD decreased at T(90) by 80% from baseline and remained decreased by 42% at T(180) (P < 0.05 vs. baseline, P < 0.05 vs. C-BLG at T90). By comparison, following C-BLG, FMD decreased by 27% at T(90) and 51% at T(180) (P < 0.05 vs. baseline at T180). A significant decrease in nitrite (T(180)) and nitrate (T(90) and T(180)), as well as a significant increase in N(ε)-carboxymethyllisine, accompanied intake of AGE-BLG. There was no change in microvascular function caused by either beverage. CONCLUSIONS: In patients with T2DM, acute oral administration of a single AGE-modified protein class significantly though transiently impaired macrovascular function in concert with decreased nitric oxide bioavailability. These AGE-related changes were independent of heat treatment. American Diabetes Association 2013-05 2013-04-13 /pmc/articles/PMC3631855/ /pubmed/23238657 http://dx.doi.org/10.2337/dc12-1489 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Stirban, Alin
Kotsi, Paraskevi
Franke, Knut
Strijowski, Ulf
Cai, Weijing
Götting, Christian
Tschoepe, Diethelm
Acute Macrovascular Dysfunction in Patients With Type 2 Diabetes Induced by Ingestion of Advanced Glycated β-Lactoglobulins
title Acute Macrovascular Dysfunction in Patients With Type 2 Diabetes Induced by Ingestion of Advanced Glycated β-Lactoglobulins
title_full Acute Macrovascular Dysfunction in Patients With Type 2 Diabetes Induced by Ingestion of Advanced Glycated β-Lactoglobulins
title_fullStr Acute Macrovascular Dysfunction in Patients With Type 2 Diabetes Induced by Ingestion of Advanced Glycated β-Lactoglobulins
title_full_unstemmed Acute Macrovascular Dysfunction in Patients With Type 2 Diabetes Induced by Ingestion of Advanced Glycated β-Lactoglobulins
title_short Acute Macrovascular Dysfunction in Patients With Type 2 Diabetes Induced by Ingestion of Advanced Glycated β-Lactoglobulins
title_sort acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631855/
https://www.ncbi.nlm.nih.gov/pubmed/23238657
http://dx.doi.org/10.2337/dc12-1489
work_keys_str_mv AT stirbanalin acutemacrovasculardysfunctioninpatientswithtype2diabetesinducedbyingestionofadvancedglycatedblactoglobulins
AT kotsiparaskevi acutemacrovasculardysfunctioninpatientswithtype2diabetesinducedbyingestionofadvancedglycatedblactoglobulins
AT frankeknut acutemacrovasculardysfunctioninpatientswithtype2diabetesinducedbyingestionofadvancedglycatedblactoglobulins
AT strijowskiulf acutemacrovasculardysfunctioninpatientswithtype2diabetesinducedbyingestionofadvancedglycatedblactoglobulins
AT caiweijing acutemacrovasculardysfunctioninpatientswithtype2diabetesinducedbyingestionofadvancedglycatedblactoglobulins
AT gottingchristian acutemacrovasculardysfunctioninpatientswithtype2diabetesinducedbyingestionofadvancedglycatedblactoglobulins
AT tschoepediethelm acutemacrovasculardysfunctioninpatientswithtype2diabetesinducedbyingestionofadvancedglycatedblactoglobulins